Chronic asthama patient complaint of increasing asthma medication after started taking bp medication
Reading File
Finding Sources
Searching PubMed
asthma AND beta-blockers
Searching the Web
GINA asthma beta blocker medication exacerbation guidance beta blockers
Reading File
The new blood-pressure medicine may be worsening the asthma, especially if it is a beta-blocker. These can cause bronchospasm and make reliever inhalers seem less effective. This includes tablets such as propranolol, atenolol, metoprolol, bisoprolol, carvedilol, and even beta-blocker eye drops such as timolol. Non-selective beta-blockers are higher risk. GINA guidance advises specialist-supervised, case-by-case use in people with asthma.
Another possible cause is an ACE inhibitor, such as ramipril, enalapril, lisinopril, or perindopril. It more often causes a persistent dry cough than true bronchospasm, but the cough may be mistaken for uncontrolled asthma. Harrison’s Principles of Internal Medicine, p. 2358.
What to do:
- Do not stop the BP medicine yourself, particularly if it is a beta-blocker.
- Contact the prescribing clinician or pharmacist promptly today to review the exact medicine, dose, timing, asthma symptoms, and inhaler use. A different BP drug may be appropriate.
- Keep using the asthma controller inhaler as prescribed. Needing the reliever increasingly is a sign that asthma control needs urgent review, not simply an automatic dose increase.
- Seek emergency care now if there is severe breathlessness, trouble speaking full sentences, blue/grey lips, marked drowsiness/confusion, chest tightness worsening despite rescue inhaler, or little/no response to the reliever.
Beta-blockers, including eye preparations, can trigger bronchospasm; more selective agents may be tolerated by some patients but can still contribute to difficult-to-control asthma. Harrison’s Principles of Internal Medicine, p. 2358. A 2025 systematic review also reassessed respiratory effects of beta-blockers in asthma (PMID 40786074); it supports careful individual risk assessment rather than assuming all agents are equally safe.
She takes telmisartan 40
Reading File
Finding Sources
Searching PubMed
telmisartan AND asthma
Searching the Web
telmisartan prescribing information cough bronchospasm asthma adverse reactions
Telmisartan 40 mg is an ARB (angiotensin-receptor blocker), not a beta-blocker. It is generally considered suitable for people with asthma and is much less likely than ACE inhibitors or beta-blockers to cause cough or bronchospasm.
So telmisartan is not the most likely reason for increased asthma medication use. In clinical trials, cough rates with telmisartan were similar to placebo in the prescribing information. Telmisartan 40 mg once daily is a standard starting dose. Brenner and Rector's The Kidney, p. 178.
However:
- If wheeze, chest tightness, or breathlessness began clearly soon after starting it, report this to the prescriber. Rare individual reactions can occur.
- Confirm it is plain telmisartan 40 mg, not a combination tablet such as telmisartan plus hydrochlorothiazide or amlodipine.
- Review other possible causes: respiratory infection, missed controller inhaler doses, poor inhaler technique, smoke/allergen exposure, reflux, NSAID painkillers such as ibuprofen/diclofenac, or a newly added medicine such as a beta-blocker or beta-blocker eye drops.
- If she is needing her rescue inhaler more than usual, arrange an asthma review promptly. Do not stop either the asthma controller or telmisartan without medical advice.
Urgent assessment is needed if she is breathless at rest, cannot speak full sentences, has blue/grey lips, or does not improve after her prescribed rescue inhaler.
Can she switch to amlodipin
Reading File
Finding Sources
Searching PubMed
amlodipine AND hypertension
Searching the Web
NICE hypertension adults amlodipine calcium channel blocker guideline 2025
Amlodipine is generally safe in asthma and does not cause the beta-blocker type of bronchospasm. It can be an appropriate blood-pressure alternative for some people.
But she should not switch from telmisartan to amlodipine on her own. Telmisartan may have added benefits in people with diabetes, protein in the urine, chronic kidney disease, heart failure, or certain cardiovascular risks, so the best choice depends on why it was prescribed and her blood pressure readings.
Ask her prescriber to review the change promptly. If they agree telmisartan is contributing, they can prescribe amlodipine at an appropriate starting dose and arrange BP follow-up. Amlodipine can cause ankle/leg swelling, flushing, headache, dizziness, or palpitations.
Since telmisartan is usually asthma-friendly, the priority is also to assess why asthma symptoms have increased, including inhaler adherence and technique, infection, allergens/smoke, NSAID use, and any other newly started medicine. Long-acting calcium-channel blockers such as amlodipine are established blood-pressure treatments. Goodman & Gilman’s The Pharmacological Basis of Therapeutics, p. 990.
She is 57 years old
Reading File
Finding Sources
Searching PubMed
hypertension AND amlodipine
Searching the Web
NICE NG136 hypertension adults treatment age 55 calcium channel blocker amlodipine
At 57 years, amlodipine is a commonly used and reasonable blood-pressure option, including for people with asthma. Some hypertension guidelines use a calcium-channel blocker such as amlodipine as a first-choice option in adults aged 55 or older, depending on their overall health profile.
However, age alone does not mean she should switch. Telmisartan is also generally asthma-safe, and may be preferred if she has:
- diabetes with kidney involvement or protein in the urine
- chronic kidney disease
- heart failure or particular cardiovascular risks
- a reason to avoid amlodipine, such as troublesome ankle swelling
The prescriber can decide whether to:
- continue telmisartan while assessing another cause of the asthma flare,
- change to amlodipine, or
- occasionally use both if BP requires more than one medicine.
She should not stop telmisartan or start amlodipine without a clinician's plan, because BP should be monitored after any change. Amlodipine is not expected to worsen asthma, but can cause ankle swelling, headache, flushing, dizziness, or palpitations. Long-acting dihydropyridine calcium-channel blockers are well-established for hypertension. Goodman & Gilman’s The Pharmacological Basis of Therapeutics, p. 990.
Because her reliever need has increased, arrange a prompt asthma review regardless of the BP-drug decision.
This is a shared conversation. Sign in to Orris to start your own chat.